Key result
ASA inhibits MPO activity by ~90% in preclinical models.
Why the study?
Long-term aspirin use may contribute to longer survival in patients with cancer, including ovarian cancer, motivating an investigation into the effect of ASA on myeloperoxidase (MPO), an enzyme found at elevated levels in women with ovarian cancer.
Does acetylsalicylic acid inhibit the activity of myeloperoxidase in vitro?
Does acetylsalicylic acid inhibit the activity of myeloperoxidase in vitro?
Aspirin significantly inhibits the chlorinating and peroxidase activity of myeloperoxidase in vitro, providing a potential biochemical mechanism for its effects in conditions associated with elevated MPO.
BACKGROUND: Acetylsalicylic acid (ASA or aspirin) is one of the world's most widely used non-steroidal anti-inflammatory drug (NSAID). Numerous studies have shown that the long-term use of aspirin may contribute to longer survival among patients with various types of cancer, including ovarian cancer. AIM: The aim of this study was to investigate the effect of ASA on myeloperoxidase (MPO), which is found at an elevated level in women with ovarian cancer, among others. METHODS: The influence of different concentrations of ASA on the chlorinating and peroxidase activity of MPO was analysed. The relationship between the concentration of ASA and the degree of inhibition of MPO activity was determined based on the results. CONCLUSIONS: Aspirin has a significant effect on MPO activity. The use of 50 mM ASA resulted in the enzyme activity being inhibited by more than 90%.
No takes yet. Share an insight, caveat, or question.
Gąsowska-Bajger et al. (2023) studied Elevated myeloperoxidase (context: ovarian cancer). Acetylsalicylic acid (ASA) was evaluated on Chlorinating and peroxidase activity of myeloperoxidase (MPO). Acetylsalicylic acid at a concentration of 50 mM inhibited the activity of myeloperoxidase by more than 90%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: